PAtient NOtifier Feature for Reduction of Anxiety

See also
Status	Clinical Trial	Phase
Terminated	`NCT01546207` - Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia	N/A
Completed	`NCT04070300` - Physical Activity and Ventricular Arrhythmias	N/A
Completed	`NCT04075253` - Acute Effect of One Single Bout of High Intensity Exercise on the Tendency for Ventricular Arrhythmia	N/A
Completed	`NCT00000531` - Antiarrhythmics Versus Implantable Defibrillators (AVID)	Phase 3
Completed	`NCT00000480` - Multicenter Unsustained Tachycardia Trial (MUSTT)	Phase 3
Completed	`NCT05086510` - Ablation Targets of Scar-related Ventricular Tachycardia Identified by Dynamic Functional Substrate Mapping	N/A
Completed	`NCT01940081` - The Leiden Nonischemic Cardiomyopathy Study
Recruiting	`NCT01222156` - Accuracy and Safety Study of the Magnetecs CGCI System for Intracardiac Mapping	Phase 1/Phase 2
Terminated	`NCT00749671` - Bispectral Index Monitoring During Testing in the Electrophysiology Lab	N/A
Recruiting	`NCT00385749` - Right Ventricular Defibrillation Lead Select Site Study	N/A
Completed	`NCT00382928` - Automatic External Defibrillation Monitoring in Cardiac Arrest	Phase 1
Completed	`NCT00279279` - PREPARE - Primary Prevention Parameters Evaluation	N/A
Terminated	`NCT00776087` - European Health Economic Trial on Home Monitoring in ICD and CRT-D Patients (EuroEco)	N/A
Withdrawn	`NCT00510731` - The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events	N/A
Completed	`NCT01572246` - Effects of Monopolar Electrocautery Use During Surgery on Implanted Cardiac Defibrillators	N/A
Completed	`NCT00170287` - SMS: Substrate Modification Study in Patients Getting an Implantable Cardioverter Defibrillator (ICD)	Phase 4
Completed	`NCT00147277` - ADVANCE-D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy	Phase 4
Completed	`NCT00004559` - Fatty Acid Antiarrhythmia Trial (FAAT)	Phase 3
Completed	`NCT00702117` - Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias	Phase 4
Completed	`NCT00232297` - Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS	Phase 2

NCT number	NCT00559559
Study type	Interventional
Source	Abbott Medical Devices
Contact
Status	Completed
Phase	N/A
Start date	December 2007
Completion date	December 2010

PAtient NOtifier Feature for Reduction of Anxiety — Panoramic

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms